Cold Therapy Following Laparoscopic Cholecystectomy

NCT07930455, Not applicable, Not yet recruiting, Mersin University

Trial 10

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Field	Value	Source
Title	Cold Therapy Following Laparoscopic Cholecystectomy	ClinicalTrials.gov
NCT number	NCT07930455	ClinicalTrials.gov
Status	Not yet recruiting	ClinicalTrials.gov
Phases	Not applicable	ClinicalTrials.gov
Enrollment	62 participants, estimated	ClinicalTrials.gov
Lead sponsor	Mersin University	ClinicalTrials.gov
Conditions	Cold Therapy Following Laparoscopic Cholecystectomy	ClinicalTrials.gov
Interventions	cold therapy	ClinicalTrials.gov
First posted	2026-11-12	ClinicalTrials.gov
Last updated	2026-11-12	ClinicalTrials.gov

Registered outcomes 4

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

List	Outcome	Time frame	Description	Source
Primary	Change from Baseline in the Pain	In patients following cold therapy, at 1, 8, and 24 hours	Visual Analog Scale (VAS): This form examines patients' demographic and clinical characteristics; it includes information on the patient's age, gender, educational status, and whether analgesics were administered following laparoscopic cholecystectomy, as well as the type and dosage if administered.	ClinicalTrials.gov
Secondary	Sleep Quality	The morning after the first night following surgery	Richard-Campbell Sleep Scale: Developed by Richards in 1987, this sleep scale consists of six items that assess the depth of nighttime sleep, the time taken to fall asleep, the frequency of awakenings, the duration of wakefulness after waking, sleep quality, and the noise level in the environment. Özlü and Özer conducted a validity and reliability study of the scale in Turkey in 2015. Each item is rated on a scale from 0 to 100 using the visual analog scale technique. On the scale, a score between "0 and 25" indicates very poor sleep, while a score between "76 and 100" indicates very good sleep. The total score is calculated based on the first five items, and the sixth item-which assesses ambient noise levels-is excluded from the total score calculation. Patients' sleep quality improves as their score on the scale increases. While the Cronbach's α value of the original scale is 0.82, that of the Turkish version is 0.91.	ClinicalTrials.gov
Secondary	Postoperative Quality of Recovery Scale	Before the patient is discharged following surgery	Quality of Recovery-15 (QoR-15): The QoR-15 was developed in 2013 as a revised and abbreviated version of the QoR-40 to assess the quality of recovery following surgery and anesthesia. This unidimensional scale is designed to assess patients' quality of recovery and well-being in the early postoperative period. It consists of a 15-item questionnaire that evaluates the patient's physical comfort, physical independence, emotional state, psychological support, and pain status. For each question on the QoR-15, the patient is asked to rate their level of recovery on a scale from 0 to 10. Once all responses are collected, a total score ranging from 0 to 150 is calculated. A total score between 136 and 150 indicates excellent recovery; between 122 and 135, good recovery; between 90 and 121, moderate recovery; and between 0 and 89, poor recovery. Validity and reliability studies of the Turkish version of the QoR-15 were conducted by Selvi et al., and Cronbach's α was found to be 0.928.	ClinicalTrials.gov
Secondary	Cold Application Chart	In patients following cold therapy, at 1, 8, and 24 hours	Cold Application Chart: Data regarding the timing of cold application to the trocar incision in the abdominal region, skin surface temperature before and after cold application, and the pre- and post-application temperatures of the cold application material (ice pack) will be recorded.	ClinicalTrials.gov

Outcomes 0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

Type	Outcome	Time frame	Population	Units	Measured as	Source

Results by group 0

Each measurement the trial posted, group by group, in the words and numbers it posted.

Outcome	Group	Category	Value	Spread	Units	Source

Participant flow 0

How many started, completed or left each group, period by period.

Period	Milestone	Group	Participants	Units counted	Source

Adverse events 0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

Type	Event	Organ system	Group	Affected	At risk	Events	Source

Adverse event totals 0

The totals the trial posted for each group.

Total	Group	Affected	At risk	Source

Papers 0

The papers the trial lists on ClinicalTrials.gov.

PMID	Listed as	Source

Trial comparisons 0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

Comparison	Source

Tests 0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

Test	Named as	Source

Source 4

Field	Value	Source
Release	trials-2026-11-12-0.3.0	ClinicalTrials.gov
Release manifest SHA-256	4a570df2e7274cee2d4fa2959402fab41880e2cd412e4b590390035fbea69391	ClinicalTrials.gov
Registry capture	2026-11-12	ClinicalTrials.gov
Results copy, AACT	2026-03-23	ClinicalTrials.gov

The same record as JSON

Release trials-2026-11-12-0.3.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.